Simplex Trading’s Nuvation Bio NUVB Stock Holding History

Simplex Trading’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Sell	23,600 -156,100	-87%	-$870K	﹤0.01%	5069
2025 Q4	$1.61M	Buy	179,700 +145,500	+425%	+$901K	﹤0.01%	2157
2025 Q3	$126K	Buy	34,200 +11,800	+53%	+$32.2K	﹤0.01%	5488
2025 Q2	$43K	Buy	22,400 +20,800	+1,300%	+$43.3K	﹤0.01%	6070
2025 Q1	$2K	Buy	+1,600	New	+$3.64K	﹤0.01%	8035
2024 Q2	–	Sell	-20,900	Closed	-$76K	–	9502
2024 Q1	$76K	Buy	+20,900	New	+$40.1K	﹤0.01%	5876
2023 Q4	–	Sell	-67,000	Closed	-$89K	–	9493
2023 Q3	$89K	Buy	+67,000	New	+$112K	﹤0.01%	5206
2022 Q2	–	Sell	-6,100	Closed	-$32K	–	10722
2022 Q1	$32K	Sell	6,100 -13,000	-68%	-$73K	﹤0.01%	7702
2021 Q4	$162K	Buy	+19,100	New	+$176K	﹤0.01%	5490

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's NUVB Position: Q1 2026 in Review

Simplex Trading opened a new position in Nuvation Bio (NUVB) in Q1 2026: 34,338 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4652 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NUVB as recently as Q3 2025.

Simplex Trading first reported a position in NUVB in Q2 2021 and has held it in 11 quarters since. The position peaked at $427K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Simplex Trading held 34,338 shares of Nuvation Bio worth $147K as of Q1 2026.
Nuvation Bio was a new Simplex Trading position in Q1 2026.
Nuvation Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4652 holding.
Simplex Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 11 quarters since.
Simplex Trading's Nuvation Bio position peaked at $427K in Q3 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.